Syros Pharmaceuticals Inc (NASDAQ:SYRS)

4.73
Delayed Data
As of 3:59pm ET
 -0.225 / -4.54%
Today’s Change
4.00
Today|||52-Week Range
15.65
-56.41%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 9.00. The median estimate represents a +280.55% increase from the last price of 4.73.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.44
Sales
$4.5M
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.53%
 
 
 
 
 
 
Growthannually 16.76%
 
 
 
 
 
 

Sales

Growthquarterly -13.12%
 
 
 
 
 
 
Growthannually 25.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.